pd 98059 has been researched along with Benign Cerebellar Neoplasms in 2 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sturla, LM | 1 |
Cowan, CW | 1 |
Guenther, L | 1 |
Castellino, RC | 1 |
Kim, JY | 1 |
Pomeroy, SL | 1 |
Chou, TT | 1 |
Trojanowski, JQ | 1 |
Lee, VM | 1 |
2 other studies available for pd 98059 and Benign Cerebellar Neoplasms
Article | Year |
---|---|
A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cerebellar Neoplasms; DNA-Binding Proteins; Enzyme Inhibitors; | 2005 |
A novel apoptotic pathway induced by nerve growth factor-mediated TrkA activation in medulloblastoma.
Topics: Apoptosis; Butadienes; Caspases; Cerebellar Neoplasms; Flavonoids; Humans; Isoenzymes; Medulloblasto | 2000 |